Treatment for infants and children with intermediate risk neuroblastoma: A phase III intergroup CCG/POG study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide
- Indications Neuroblastoma
- Focus Therapeutic Use
- 01 Aug 2014 Biomarkers information updated
- 17 Apr 2012 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
- 17 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.